Cargando…
The Prognosis of Advanced Non-Small Cell Lung Cancer Patients with Precision-Targeted Therapy Guided by NGS Testing or Routine Testing
PURPOSE: We aim to observe the potential survival benefits of driver gene-guided targeted therapy in advanced non-small cell lung cancer (NSCLC) patients compared to non-targeted therapy. Additionally, the study aims to assess whether Next-generation sequencing technology (NGS)-guided targeted thera...
Autores principales: | Tu, Tingting, Chen, Dandan, Jiang, Houjun, Ma, Jianhua, Wang, Hongwei, Chen, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658950/ https://www.ncbi.nlm.nih.gov/pubmed/38027245 http://dx.doi.org/10.2147/CMAR.S436808 |
Ejemplares similares
-
Learnings From Precision Clinical Trial Matching for Oncology Patients Who Received NGS Testing
por: Jain, Neha M., et al.
Publicado: (2021) -
The potential of high-order features of routine blood test in predicting the prognosis of non-small cell lung cancer
por: Luo, Liping, et al.
Publicado: (2023) -
Genetic Testing Requires NGS and Sanger Methodologies
por: Jennings, Lawrence J., et al.
Publicado: (2016) -
Analytical Evaluation of an NGS Testing Method for Routine Molecular Diagnostics on Melanoma Formalin-Fixed, Paraffin-Embedded Tumor-Derived DNA
por: Mancini, Irene, et al.
Publicado: (2019) -
Evaluating next‐generation sequencing (NGS) methods for routine monitoring of wild bees: Metabarcoding, mitogenomics or NGS barcoding
por: Gueuning, Morgan, et al.
Publicado: (2019)